Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXA3IN
|
||||
Drug Name |
N-(4-bromophenethyl)-N-((4-(4-cyanobenzyl)-4H-1,2,4-triazol-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
|
||||
Synonyms |
CHEMBL370381
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H22BrN5O3
|
||||
Canonical SMILES |
Brc1ccc(CCN(Cc2nncn2Cc3ccc(cc3)C#N)C(=O)c4ccc5OCOc5c4)cc1
|
||||
InChI |
InChI=1S/C27H22BrN5O3/c28-23-8-5-19(6-9-23)11-12-32(27(34)22-7-10-24-25(13-22)36-18-35-24)16-26-31-30-17-33(26)15-21-3-1-20(14-29)2-4-21/h1-10,13,17H,11-12,15-16,18H2
|
||||
InChIKey |
OUWQTHFUUVTNSV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.